NCT05719129

Brief Summary

The study approach is to leverage the most cutting-edge techniques of multi-omics biology, wearable physiology, and digital real-time psychology profiling and using machine learning models to understand the mechanisms underlying the strategies and techniques that enable participants the power to initiate and maintain sustainable behavior change. Over the years, millions of people worldwide have attended immersive personal development seminars aiming to improve participants' health behaviors and wellness. Nevertheless, there's a scarcity of large-scale studies to assess their effects on behavior change and investigate their mechanism of action. A recent publication by the Science of Behavior Change Program (SOBC), launched by the National Institute of Health (NIH), recognized that: "science has not yet delivered a unified understanding of basic mechanisms of behavior change across a broad range of health-related behaviors, limiting progress in the development and translation of effective and efficacious behavioral intervention." As such, understanding the mechanisms underlying sustainable behavior change is key.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,445

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 30, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 22, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 8, 2023

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

November 25, 2024

Status Verified

November 1, 2024

Enrollment Period

3 years

First QC Date

January 22, 2023

Last Update Submit

November 20, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Mental performance biomarker index.

    An algorithm will be used to create an index score using known biomarkers (psychosocial, physiological, and biological) related to participants' personalized mental performance. Higher index scores will indicate a better mental performance index. This outcome is assessed in the DWD group only.

    one-year

  • Change from baseline in Oldenburg Burnout Inventory score (OLBI)

    Participant self-report burnout assessed by OBLI survey, a 16-item questionarie assesing disengagement and exhaustion with a score range of 16-64, where higher scores indicate higher burnout; assessed in all participants.

    baseline through year one

  • Change from baseline in Percieved Stress Scale score (PSS-10)

    Participant self-report perceived stress assessed by the Perceived Stress Scale (PSS-10), a 10-item questionnaire with a score range of 0-40, where higher scores indicate greater perceived stress; assessed in all participants.

    baseline through year one

  • Change from baseline in well-being score.

    Participant self-report well-being assessed by the PERMA-H Profiler, a 23-item questionnaire measuring psychological well-being across five domains: positive and negative emotions, engagement, relationships, meaning, and accomplishment (range 0-10 per item, higher scores indicate greater well-being); assessed in all participants.

    baseline through year one

  • Change from baseline in subjective health score.

    Participant self-report subjective health assessed by the health domain in the PERMA-H Profiler (range 0-10 per item, higher scores indicate higher subjective health); assessed in all participants.

    baseline through year one

Secondary Outcomes (10)

  • Change from baseline in Connor-Davidson Resilience Scale (CD-RISC-10)

    baseline through year one

  • Change from baseline in General Self-Efficacy Scale (GSE-10)

    baseline through year one

  • Change from baseline in Gratitude Questionnaire-Six Item Form (GQ-6)

    baseline through year one

  • Ecological Momentary Assessments (EMAs) score

    baseline through year one

  • Professional Fulfillment Index (PFI) score

    baseline through year one

  • +5 more secondary outcomes

Study Arms (2)

DWD participants

Individuals that voluntarily chose to participate in DWD seminar.

Behavioral: Date With Destiny (DWD) Seminar

Matched control group

Individuals that voluntarily chose to from the US population matched by gender, age, education, ethnicity and income

Interventions

6 days of immersive seminar

DWD participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals that voluntarily chose to participate in DWD seminar.

You may qualify if:

  • years-old and older
  • English speaker
  • Live in the US
  • Participate in the DWD seminar (December 2-7, 2022)

You may not qualify if:

  • Any physical or mental condition that limits the ability to participate in the study (e.g., answering e-questionnaires and wearing an electronic device)
  • Serious active comorbidity or terminal illness
  • Pregnancy
  • Participation in any other clinical study focusing on psychological or behavioral intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford university

Palo Alto, California, 94305, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

A subgroup of up to 300 participants will also undergo a microbiome sampling and will provide saliva and fasted blood samples at (see details below): (a) up to two weeks before DWD, as baseline; (b) at the end of the event. (c) one month after the event; (d) 3 months after the event; (e) 6 months after the event; (f) and one year after the event.

MeSH Terms

Conditions

Psychological Well-Being

Interventions

Chronology as Topic

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Intervention Hierarchy (Ancestors)

TimePhysical Phenomena

Study Officials

  • Mike Snyder, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Shahar Lev-Ari, PhD

    Stanford University & Tel-Aviv University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chair, Dept. of Genetics

Study Record Dates

First Submitted

January 22, 2023

First Posted

February 8, 2023

Study Start

November 30, 2022

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

November 25, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

The data that support the findings of this study will be available from the corresponding authors upon reasonable request. To protect participant privacy, individual-level data are not publicly available due to the sensitive nature of psychological and health-related information. Aggregated data and analysis scripts used to generate the main results and figures will be deposited in a public repository upon publication. Any additional data or materials required to replicate the reported findings that are not included in the public repository will be made available by the corresponding authors upon reasonable request, subject to institutional review board approval for sharing of de-identified data.

Locations